An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults

ABSTRACTSARS-CoV-2 Omicron subvariants have become the predominantly strain in most countries. However, the neutralizing activity of the human serum after Omicron-based vaccine booster against different SARS-CoV-2 variants is poorly understood. Here, we developed an update Omicron vaccine (SCoK-Omic...

Full description

Bibliographic Details
Main Authors: Tao Li, Deyan Luo, Nianzhi Ning, Xin Wang, Liangyan Zhang, Xiaolan Yang, Deyu Li, Yakun Sun, Wenjing Yu, Wenjin Wei, Hui Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2023.2207670